Disease | hemophilia |
Comorbidity | C0040053|thrombosis |
Sentences | 8 |
PubMedID- 21127694 | Conclusion: according to our case we consider the false clinical picture of 'tense ascites' of our patient as a rare clinical presentation of decompensated liver cirrhosis, with severe edema of mesenterium and viscus, on the grounds of preexisting portal vein thrombosis, in a patient with combined hemophilia a and thrombophilia v leiden. |
PubMedID- 22507808 | thrombosis in hemophilia patients has a multifactorial pathogenesis and the main conditions associated with this complication are the use of long-term central venous catheters, intensive replacement therapy usually in the setting of surgical procedures, the use of bypassing agents or the coexistence of acquired or inherited prothrombotic risk factors. |
PubMedID- 19412729 | Several reports have dealt with the occurrence of both arterial and venous thrombosis in patients with haemophilia a, haemophilia b, and von willebrand disease. |
PubMedID- 23681676 | The ratio of arterial versus venous thrombosis in hemophilia a is 3.72 whereas that for hemophilia b is 1.12. |
PubMedID- 23026653 | It is important for the future to establish risk assessment tools that can help to determine the most effective and safe practice to prevent venous thrombosis in patients with hemophilia and other bleeding disorders who undergo surgical procedures. |
PubMedID- 21088757 | Bovenzi et al.11) reported a case of acute stent thrombosis in a patient with hemophilia b after coronary stent implantation who was not treated with aspirin or clopidogrel. |
PubMedID- 25708424 | However, a retrospective study reported subclinical deep venous thrombosis (dvt) in 10% of patients with haemophilia undergoing major orthopaedic surgery. |
PubMedID- 24244342 | Activated pccs have already shown an enhanced risk of thrombosis when used in patients with hemophilia [41] and this risk would be expected to increase if applied to patients with an underlying prothrombotic condition. |
Page: 1